Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults
Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels of cerebrospinal fluid tau in women compared with men as a function of apolipoprotein E (APOE) ε4 status and β-amyloid (Aβ). What remains unclear is the...
Saved in:
Published in | Archives of neurology (Chicago) Vol. 76; no. 5; p. 542 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Medical Association
01.05.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 2168-6149 2168-6157 |
DOI | 10.1001/jamaneurol.2018.4693 |
Cover
Abstract | Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels of cerebrospinal fluid tau in women compared with men as a function of apolipoprotein E (APOE) ε4 status and β-amyloid (Aβ). What remains unclear is the association of sex with regional tau deposition in clinically normal individuals.
To examine sex differences in the cross-sectional association between Aβ and regional tau deposition as measured with positron emission tomography (PET).
This is a study of 2 cross-sectional, convenience-sampled cohorts of clinically normal individuals who received tau and Aβ PET scans. Data were collected between January 2016 and February 2018 from 193 clinically normal individuals from the Harvard Aging Brain Study (age range, 55-92 years; 118 women [61%]) who underwent carbon 11-labeled Pittsburgh Compound B and flortaucipir F18 PET and 103 clinically normal individuals from the Alzheimer's Disease Neuroimaging Initiative (age range, 63-94 years; 55 women [51%]) who underwent florbetapir and flortaucipir F 18 PET.
A main association of sex with regional tau in the entorhinal cortices, inferior temporal lobe, and a meta-region of interest, which was a composite of regions in the temporal lobe. Associations between sex and global Aβ as well as sex and APOE ε4 on these regions after controlling for age were also examined.
The mean (SD) age of all individuals was 74.2 (7.6) years (81 APOE ε4 carriers [31%]; 89 individuals [30%] with high Aβ). There was no clear association of sex with regional tau that was replicated across studies. However, in both cohorts, clinically normal women exhibited higher entorhinal cortical tau than men (meta-analytic estimate: β [male] = -0.11 [0.05]; 95% CI, -0.21 to -0.02; P = .02), which was associated with individuals with higher Aβ burden. A sex by APOE ε4 interaction was not associated with regional tau (meta-analytic estimate: β [male, APOE ε4+] = -0.15 [0.09]; 95% CI, -0.32 to 0.01; P = .07).
Early tau deposition was elevated in women compared with men in individuals on the Alzheimer disease trajectory. These findings lend support to a growing body of literature that highlights a biological underpinning for sex differences in Alzheimer disease risk. |
---|---|
AbstractList | Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels of cerebrospinal fluid tau in women compared with men as a function of apolipoprotein E (APOE) ε4 status and β-amyloid (Aβ). What remains unclear is the association of sex with regional tau deposition in clinically normal individuals.
To examine sex differences in the cross-sectional association between Aβ and regional tau deposition as measured with positron emission tomography (PET).
This is a study of 2 cross-sectional, convenience-sampled cohorts of clinically normal individuals who received tau and Aβ PET scans. Data were collected between January 2016 and February 2018 from 193 clinically normal individuals from the Harvard Aging Brain Study (age range, 55-92 years; 118 women [61%]) who underwent carbon 11-labeled Pittsburgh Compound B and flortaucipir F18 PET and 103 clinically normal individuals from the Alzheimer's Disease Neuroimaging Initiative (age range, 63-94 years; 55 women [51%]) who underwent florbetapir and flortaucipir F 18 PET.
A main association of sex with regional tau in the entorhinal cortices, inferior temporal lobe, and a meta-region of interest, which was a composite of regions in the temporal lobe. Associations between sex and global Aβ as well as sex and APOE ε4 on these regions after controlling for age were also examined.
The mean (SD) age of all individuals was 74.2 (7.6) years (81 APOE ε4 carriers [31%]; 89 individuals [30%] with high Aβ). There was no clear association of sex with regional tau that was replicated across studies. However, in both cohorts, clinically normal women exhibited higher entorhinal cortical tau than men (meta-analytic estimate: β [male] = -0.11 [0.05]; 95% CI, -0.21 to -0.02; P = .02), which was associated with individuals with higher Aβ burden. A sex by APOE ε4 interaction was not associated with regional tau (meta-analytic estimate: β [male, APOE ε4+] = -0.15 [0.09]; 95% CI, -0.32 to 0.01; P = .07).
Early tau deposition was elevated in women compared with men in individuals on the Alzheimer disease trajectory. These findings lend support to a growing body of literature that highlights a biological underpinning for sex differences in Alzheimer disease risk. Importance Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels of cerebrospinal fluid tau in women compared with men as a function of apolipoprotein E (APOE) ε4 status and β-amyloid (Aβ). What remains unclear is the association of sex with regional tau deposition in clinically normal individuals. Objective To examine sex differences in the cross-sectional association between Aβ and regional tau deposition as measured with positron emission tomography (PET). Design, Setting and Participants This is a study of 2 cross-sectional, convenience-sampled cohorts of clinically normal individuals who received tau and Aβ PET scans. Data were collected between January 2016 and February 2018 from 193 clinically normal individuals from the Harvard Aging Brain Study (age range, 55-92 years; 118 women [61%]) who underwent carbon 11–labeled Pittsburgh Compound B and flortaucipir F18 PET and 103 clinically normal individuals from the Alzheimer’s Disease Neuroimaging Initiative (age range, 63-94 years; 55 women [51%]) who underwent florbetapir and flortaucipir F 18 PET. Main Outcomes and Measures A main association of sex with regional tau in the entorhinal cortices, inferior temporal lobe, and a meta-region of interest, which was a composite of regions in the temporal lobe. Associations between sex and global Aβ as well as sex and APOE ε4 on these regions after controlling for age were also examined. Results The mean (SD) age of all individuals was 74.2 (7.6) years (81 APOE ε4 carriers [31%]; 89 individuals [30%] with high Aβ). There was no clear association of sex with regional tau that was replicated across studies. However, in both cohorts, clinically normal women exhibited higher entorhinal cortical tau than men (meta-analytic estimate: β [male] = −0.11 [0.05]; 95% CI, −0.21 to −0.02; P = .02), which was associated with individuals with higher Aβ burden. A sex by APOE ε4 interaction was not associated with regional tau (meta-analytic estimate: β [male, APOE ε4+] = −0.15 [0.09]; 95% CI, −0.32 to 0.01; P = .07). Conclusions and Relevance Early tau deposition was elevated in women compared with men in individuals on the Alzheimer disease trajectory. These findings lend support to a growing body of literature that highlights a biological underpinning for sex differences in Alzheimer disease risk. |
Author | Buckley, Rachel F Farrell, Michelle Papp, Kathryn V Johnson, Keith A Hohman, Timothy J Jacobs, Heidi I L Kirn, Dylan Schultz, Aaron P Hedden, Trey Mormino, Elizabeth C Rabin, Jennifer S Hanseeuw, Bernard J Amariglio, Rebecca E Scott, Matthew R Rentz, Dorene M Villemagne, Victor L Properzi, Michael J Landau, Susan Chhatwal, Jasmeer Sperling, Reisa A Price, Julie |
Author_xml | – sequence: 1 givenname: Rachel F surname: Buckley fullname: Buckley, Rachel F organization: Melbourne School of Psychological Science, University of Melbourne, Victoria, Australia – sequence: 2 givenname: Elizabeth C surname: Mormino fullname: Mormino, Elizabeth C organization: Department of Neurology, Stanford University, Stanford, California – sequence: 3 givenname: Jennifer S surname: Rabin fullname: Rabin, Jennifer S organization: Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston – sequence: 4 givenname: Timothy J surname: Hohman fullname: Hohman, Timothy J organization: Vanderbilt Memory & Alzheimer's Center, Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee – sequence: 5 givenname: Susan surname: Landau fullname: Landau, Susan organization: Helen Wills Neuroscience Institute, University of California Berkeley, Berkeley – sequence: 6 givenname: Bernard J surname: Hanseeuw fullname: Hanseeuw, Bernard J organization: Department of Neurology, Cliniques Universitaires St-Luc, Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium – sequence: 7 givenname: Heidi I L surname: Jacobs fullname: Jacobs, Heidi I L organization: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston – sequence: 8 givenname: Kathryn V surname: Papp fullname: Papp, Kathryn V organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts – sequence: 9 givenname: Rebecca E surname: Amariglio fullname: Amariglio, Rebecca E organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts – sequence: 10 givenname: Michael J surname: Properzi fullname: Properzi, Michael J organization: Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston – sequence: 11 givenname: Aaron P surname: Schultz fullname: Schultz, Aaron P organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts – sequence: 12 givenname: Dylan surname: Kirn fullname: Kirn, Dylan organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts – sequence: 13 givenname: Matthew R surname: Scott fullname: Scott, Matthew R organization: Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston – sequence: 14 givenname: Trey surname: Hedden fullname: Hedden, Trey organization: Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston – sequence: 15 givenname: Michelle surname: Farrell fullname: Farrell, Michelle organization: Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston – sequence: 16 givenname: Julie surname: Price fullname: Price, Julie organization: Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston – sequence: 17 givenname: Jasmeer surname: Chhatwal fullname: Chhatwal, Jasmeer organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts – sequence: 18 givenname: Dorene M surname: Rentz fullname: Rentz, Dorene M organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts – sequence: 19 givenname: Victor L surname: Villemagne fullname: Villemagne, Victor L organization: Department of Nuclear Medicine and Centre for PET, Austin Health, Victoria, Australia – sequence: 20 givenname: Keith A surname: Johnson fullname: Johnson, Keith A organization: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston – sequence: 21 givenname: Reisa A surname: Sperling fullname: Sperling, Reisa A organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30715078$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kMtOwzAQRS0EolD6BwhZYt3iV5xkWbXlIZWHoKwrJx6DKycudiKRb-FnSaEwmxmde3VHM6fosPY1IHROyYQSQq82qlI1tMG7CSM0mwiZ8wN0wqjMxpIm6eH_LPIBGsW4IX1lhAgujtGAk5QmJM1O0NcLfOK5NQYC1CVEbGvcvAOexuhLqxrra-wNvnG-UA5Pq855q7GqNX6Gt17s4Uq1eA5bH-2P-x5UbANoXHT4aQdDDxeVjXGnrnzl34Lavne7TTNna1sq5zr84EPVhz06DQFPdeuaeIaOjHIRRvs-RK_Xi9Xsdrx8vLmbTZdjlTDajMskldSkkmWSUTA8V7Q0GpJUa6kILVLBpdFK81wUJhcZYzkUGaU6oyllXPMhuvzN3Qb_0UJs1hvfhv60uGZMJFLkCZe962LvaosK9HobbKVCt_77Jf8GaZF84g |
CitedBy_id | crossref_primary_10_1186_s13195_022_01106_4 crossref_primary_10_1016_j_neuroimage_2022_119761 crossref_primary_10_1186_s13195_022_00973_1 crossref_primary_10_1177_0271678X211062274 crossref_primary_10_1126_scitranslmed_aaz5677 crossref_primary_10_3389_fnagi_2024_1480332 crossref_primary_10_1016_j_neurobiolaging_2021_03_007 crossref_primary_10_1016_j_parkreldis_2023_105454 crossref_primary_10_1007_s00259_020_05099_w crossref_primary_10_1093_braincomms_fcaa025 crossref_primary_10_1016_S0140_6736_20_31561_0 crossref_primary_10_1007_s11357_022_00588_2 crossref_primary_10_1016_j_nicl_2019_102025 crossref_primary_10_1007_s11357_023_00982_4 crossref_primary_10_1016_j_arr_2021_101459 crossref_primary_10_1111_ene_14174 crossref_primary_10_1016_j_neurobiolaging_2021_03_010 crossref_primary_10_1002_alz_13158 crossref_primary_10_1016_j_nicl_2023_103532 crossref_primary_10_1002_jnr_24739 crossref_primary_10_3389_fnagi_2021_691691 crossref_primary_10_1001_jamaneurol_2019_2899 crossref_primary_10_1093_braincomms_fcab126 crossref_primary_10_1093_braincomms_fcad305 crossref_primary_10_1093_brain_awad317 crossref_primary_10_1002_alz_12501 crossref_primary_10_1002_trc2_12154 crossref_primary_10_3233_JAD_190465 crossref_primary_10_1002_ana_25878 crossref_primary_10_3389_fnagi_2019_00242 crossref_primary_10_1088_1741_2552_ac37cc crossref_primary_10_1186_s12974_024_03020_y crossref_primary_10_3390_genes12060917 crossref_primary_10_1016_S1474_4422_22_00408_2 crossref_primary_10_3390_neuroglia6010002 crossref_primary_10_1002_alz_12952 crossref_primary_10_1080_14740338_2024_2448205 crossref_primary_10_3389_fnins_2022_954999 crossref_primary_10_3390_ijms24076354 crossref_primary_10_3233_ADR_200214 crossref_primary_10_3390_v15061319 crossref_primary_10_1007_s12264_021_00814_5 crossref_primary_10_1016_j_brainres_2019_146385 crossref_primary_10_1159_000507977 crossref_primary_10_1242_dmm_045211 crossref_primary_10_1186_s13195_023_01162_4 crossref_primary_10_1016_j_neuron_2024_01_024 crossref_primary_10_1002_gps_5809 crossref_primary_10_3390_genes14040917 crossref_primary_10_1016_j_neurobiolaging_2021_04_003 crossref_primary_10_1016_j_neuint_2023_105499 crossref_primary_10_1001_jamaneurol_2021_5181 crossref_primary_10_3233_JAD_230527 crossref_primary_10_1038_s41380_024_02838_5 crossref_primary_10_1093_cercor_bhac491 crossref_primary_10_3389_fnsys_2021_685957 crossref_primary_10_1002_alz_70004 crossref_primary_10_3233_JAD_231186 crossref_primary_10_3389_fnagi_2022_829202 crossref_primary_10_1016_j_neurobiolaging_2023_06_013 crossref_primary_10_1089_neur_2023_0051 crossref_primary_10_1053_j_semnuclmed_2024_01_010 crossref_primary_10_1155_2024_8839631 crossref_primary_10_1177_00914150241253257 crossref_primary_10_1001_jamaneurol_2023_0455 crossref_primary_10_1002_alz_12662 crossref_primary_10_1186_s13293_024_00620_4 crossref_primary_10_1007_s00259_023_06280_7 crossref_primary_10_1002_alz_12422 crossref_primary_10_3390_brainsci13081195 crossref_primary_10_1212_WNL_0000000000200137 crossref_primary_10_3389_fgwh_2023_1289096 crossref_primary_10_1177_1535370220920552 crossref_primary_10_3389_fnins_2020_525970 crossref_primary_10_1007_s13311_021_01026_5 crossref_primary_10_1016_j_neuroimage_2022_119621 crossref_primary_10_1186_s13195_024_01601_w crossref_primary_10_1002_alz_12989 crossref_primary_10_1016_j_bbi_2020_05_014 crossref_primary_10_1002_alz_13844 crossref_primary_10_3233_JAD_215273 crossref_primary_10_1002_dad2_12211 crossref_primary_10_1016_j_arr_2021_101542 crossref_primary_10_1093_brain_awac257 crossref_primary_10_2967_jnumed_120_261881 crossref_primary_10_1093_brain_awad100 crossref_primary_10_1016_j_neurot_2024_e00426 crossref_primary_10_1001_jamaneurol_2019_5154 crossref_primary_10_1093_brain_awab160 crossref_primary_10_1097_QAI_0000000000003184 crossref_primary_10_1016_S1474_4422_23_00128_X crossref_primary_10_1001_jamaneurol_2023_4038 crossref_primary_10_1186_s13550_024_01193_4 crossref_primary_10_1002_alz_12759 crossref_primary_10_1515_revneuro_2023_0108 crossref_primary_10_1016_j_neurobiolaging_2022_05_003 crossref_primary_10_1002_dad2_12565 crossref_primary_10_1038_s41380_024_02753_9 crossref_primary_10_1002_ana_26382 crossref_primary_10_1186_s13195_024_01509_5 crossref_primary_10_3233_JAD_215260 crossref_primary_10_1073_pnas_1904673116 crossref_primary_10_1007_s00330_023_10366_z crossref_primary_10_1007_s13311_023_01408_x crossref_primary_10_1002_alz_12087 crossref_primary_10_1212_WNL_0000000000011081 crossref_primary_10_1016_j_nicl_2021_102708 crossref_primary_10_1186_s13195_022_01081_w crossref_primary_10_1177_0271678X231196978 crossref_primary_10_1007_s11920_020_01202_y crossref_primary_10_1186_s13293_020_00310_x crossref_primary_10_1002_acn3_51102 crossref_primary_10_1186_s13024_022_00590_4 crossref_primary_10_1126_sciadv_adt1288 crossref_primary_10_1038_s44321_024_00190_3 crossref_primary_10_1186_s13195_021_00902_8 crossref_primary_10_1002_alz_13546 crossref_primary_10_1073_pnas_2406854121 crossref_primary_10_1162_imag_a_00369 crossref_primary_10_1186_s13195_023_01178_w crossref_primary_10_1126_sciadv_adt0757 crossref_primary_10_1001_jamaneurol_2024_2843 crossref_primary_10_1038_s41591_023_02380_x crossref_primary_10_15252_emmm_202012921 crossref_primary_10_3389_frdem_2024_1496051 crossref_primary_10_1212_WNL_0000000000009781 crossref_primary_10_1002_dad2_12271 crossref_primary_10_1007_s00259_020_05118_w crossref_primary_10_1016_j_neurobiolaging_2021_05_013 crossref_primary_10_1002_alz_13432 crossref_primary_10_3233_ADR_230131 crossref_primary_10_1016_j_mad_2023_111821 crossref_primary_10_3390_ijms24032166 crossref_primary_10_1002_alz_14405 crossref_primary_10_1002_alz_13314 crossref_primary_10_1093_brain_awaa327 crossref_primary_10_1016_j_biopsych_2023_09_003 crossref_primary_10_3233_JAD_210434 crossref_primary_10_3233_JAD_220905 crossref_primary_10_1093_brain_awad397 crossref_primary_10_1212_WNL_0000000000008682 crossref_primary_10_1002_dmrr_3401 crossref_primary_10_1007_s12035_021_02591_8 crossref_primary_10_1212_WNL_0000000000010527 crossref_primary_10_3390_ijms242417377 crossref_primary_10_1186_s13195_024_01446_3 crossref_primary_10_1002_alz_12552 crossref_primary_10_1016_j_psyneuen_2021_105248 crossref_primary_10_1002_dad2_12016 crossref_primary_10_1186_s13195_025_01684_z crossref_primary_10_1111_jnc_15834 crossref_primary_10_1016_j_yfrne_2025_101184 crossref_primary_10_1016_j_dadm_2019_07_007 crossref_primary_10_1186_s13024_021_00452_5 crossref_primary_10_3233_JAD_210341 crossref_primary_10_1016_j_cell_2022_09_002 crossref_primary_10_3390_biom14121518 crossref_primary_10_1007_s00401_020_02152_8 crossref_primary_10_1001_jamaneurol_2019_4421 crossref_primary_10_1038_s41582_019_0228_7 crossref_primary_10_1016_S0140_6736_20_32205_4 crossref_primary_10_3390_life13081676 crossref_primary_10_1017_S1355617721000801 crossref_primary_10_1002_dad2_12121 crossref_primary_10_1001_jamanetworkopen_2019_13909 crossref_primary_10_1038_s44294_024_00021_3 crossref_primary_10_3389_fnagi_2022_825996 crossref_primary_10_3389_fnimg_2022_978350 crossref_primary_10_1002_ana_26588 crossref_primary_10_1001_jamanetworkopen_2021_1001 crossref_primary_10_1016_j_nicl_2021_102620 crossref_primary_10_1177_1756286419888819 crossref_primary_10_1126_sciadv_adt9243 crossref_primary_10_1002_alz_14435 crossref_primary_10_1093_brain_awac316 crossref_primary_10_1016_j_cell_2022_09_029 crossref_primary_10_1016_j_neurobiolaging_2020_08_020 crossref_primary_10_1186_s13024_020_00413_4 crossref_primary_10_1001_jamanetworkopen_2021_24124 crossref_primary_10_1002_alz_13460 crossref_primary_10_3390_biom13010026 crossref_primary_10_53053_SSNO9455 crossref_primary_10_1016_j_neurobiolaging_2023_10_002 crossref_primary_10_1016_j_neurobiolaging_2021_01_026 crossref_primary_10_1016_j_tem_2021_09_004 crossref_primary_10_1186_s13195_024_01653_y crossref_primary_10_3233_JAD_201014 crossref_primary_10_1002_trc2_12080 crossref_primary_10_1073_pnas_2416042122 crossref_primary_10_1007_s00259_019_04669_x crossref_primary_10_3390_biom13071115 crossref_primary_10_1002_hup_2838 crossref_primary_10_1016_j_jarlif_2025_100001 crossref_primary_10_1038_s41746_023_00978_6 crossref_primary_10_1093_cercor_bhae299 crossref_primary_10_3233_JAD_200293 crossref_primary_10_3390_ijms25073964 crossref_primary_10_1093_sleep_zsac135 crossref_primary_10_1186_s12974_025_03404_8 crossref_primary_10_1001_jamaneurol_2023_1059 crossref_primary_10_1001_jamaneurol_2025_0013 crossref_primary_10_1016_j_neuroimage_2020_116944 crossref_primary_10_1289_EHP8428 crossref_primary_10_3233_JAD_200723 crossref_primary_10_1186_s12974_020_02046_2 crossref_primary_10_7554_eLife_81067 crossref_primary_10_1038_s41467_020_15701_2 crossref_primary_10_3233_JAD_191183 crossref_primary_10_3233_JAD_210406 crossref_primary_10_1016_j_neurobiolaging_2021_12_010 crossref_primary_10_1093_cercor_bhae067 crossref_primary_10_1007_s12264_022_00836_7 crossref_primary_10_1002_alz_13454 crossref_primary_10_2147_NDT_S403854 crossref_primary_10_1002_dad2_12284 crossref_primary_10_1097_WAD_0000000000000393 crossref_primary_10_1212_NXG_0000000000200043 crossref_primary_10_3389_fphar_2021_746491 crossref_primary_10_1186_s13195_022_00991_z crossref_primary_10_1016_j_jphs_2021_03_006 |
ContentType | Journal Article |
Copyright | Copyright American Medical Association May 2019 |
Copyright_xml | – notice: Copyright American Medical Association May 2019 |
DBID | CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K K9. NAPCQ |
DOI | 10.1001/jamaneurol.2018.4693 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2168-6157 |
ExternalDocumentID | 30715078 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIA NIH HHS grantid: K01 AG049164 – fundername: NIA NIH HHS grantid: P30 AG062421 – fundername: NIA NIH HHS grantid: P01 AG036694 – fundername: NIA NIH HHS grantid: K24 AG035007 – fundername: NIA NIH HHS grantid: R01 AG046396 – fundername: NIA NIH HHS grantid: K99 AG061238 – fundername: NIA NIH HHS grantid: K01 AG051718 – fundername: NIA NIH HHS grantid: R01 AG059716 – fundername: NIA NIH HHS grantid: R21 AG059941 – fundername: NIA NIH HHS grantid: R00 AG061238 |
GroupedDBID | 0R~ 4.4 53G AAGZG ABIVO ABJNI ACDNT ACGFS ACPRK ADBBV ADHGD AENEX AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AMJDE ANMPU BRYMA C45 CGR CUY CVF EBD EBS ECM EIF EJD EMOBN EX3 H13 NPM OB2 OBH OHH OVD PQQKQ RAJ SV3 TEORI WOW --- -QF .XZ 23N 2WC 354 39C 5GY 6J9 7TK 7U7 AAWTL ABCQX ABOCM ACGFO AFOSN C1A C1K CS3 E3Z EAM F5P GX1 K9. L7B MJL N9A NAPCQ P2P RXW SJN TWZ VVN WH7 X6Y XHN YOC ZY1 |
ID | FETCH-LOGICAL-a521t-c5761f7628621ef39a1cfde57dd6a01b7436fdad394bf948229eb811d817123d3 |
ISSN | 2168-6149 |
IngestDate | Sat Jul 26 02:16:19 EDT 2025 Thu Apr 03 07:07:33 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a521t-c5761f7628621ef39a1cfde57dd6a01b7436fdad394bf948229eb811d817123d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
OpenAccessLink | http://hdl.handle.net/2078/213494 |
PMID | 30715078 |
PQID | 2245649536 |
PQPubID | 42446 |
ParticipantIDs | proquest_journals_2245649536 pubmed_primary_30715078 |
PublicationCentury | 2000 |
PublicationDate | 2019-05-01 |
PublicationDateYYYYMMDD | 2019-05-01 |
PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Chicago |
PublicationTitle | Archives of neurology (Chicago) |
PublicationTitleAlternate | JAMA Neurol |
PublicationYear | 2019 |
Publisher | American Medical Association |
Publisher_xml | – name: American Medical Association |
SSID | ssj0000800434 ssj0012889 |
Score | 2.663492 |
Snippet | Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels of... Importance Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 542 |
SubjectTerms | Age Aged Aged, 80 and over Aging Alzheimer's disease Amyloid beta-Peptides - metabolism Aniline Compounds Apolipoprotein E Apolipoprotein E4 - genetics Brain Brain - diagnostic imaging Brain - metabolism Carbolines Cerebrospinal fluid Contrast Media Cortex Cross-Sectional Studies Deposition Emission analysis Emission measurements Entorhinal Cortex - diagnostic imaging Entorhinal Cortex - metabolism Ethylene Glycols Female Gender aspects Gender differences Health risks Healthy Volunteers Humans Male Medical imaging Men Middle Aged Neurodegenerative diseases Neuroimaging Neurology Older people Positron emission Positron emission tomography Regional analysis Sex Sex differences Sex Factors Tau protein tau Proteins - metabolism Temporal lobe Temporal Lobe - diagnostic imaging Temporal Lobe - metabolism Thiazoles Tomography Trajectories Women β-Amyloid |
Title | Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30715078 https://www.proquest.com/docview/2245649536 |
Volume | 76 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBZZB2MvY7_brhv3sLfgUMe2LD-GkRJGnZbNgbwZy5K3QhOPJoF1_0r_tv0vu5Pk2Ml-sO1FBEHsoPsi3Z2--46xtzooE14FhVcmAgOUsFCeKHEz5IFOhFZULUq1w-mUT2bh-3k07_W-d1hLm7UclN9-WVfyP1bFObQrVcn-g2W3D8UJ_Iz2xREtjONf2fij_op7VuVK9lYNZ7Gz5OQLWln__miBsfmVchWJn2wKMCs2uOU0zK1-ajOGxim9pMkbnBwjFCin1s_qhRO4NrWCrqby-pYufxb4sAvq-N0fkaLHquv0dtVtjX6mkX2i62PLA-lkI9xVszE8SU1ft8zjtCbaTr3DRWtzvB8K6fqKObpOm9Od1J9dmtcB012FuVwHlVdFO7yR_UusfQibfXPoc4ERsVVCHejunNXCbjZ-23jGATzq7OKRFfz66XRpuxrYxSJmoBiE3PZ43BXznl7kZ7Pz8zwbz7N77P4wRteOatHnWwYSegamQ-P2924rO60o1v47fh8DGV8oe8weuSAGRhaRT1hPL5-yB6mjaTxjdwhM6AATrpaAwITOQkJdgQUmOGACAhMaYAICE1pgQgNMkLfQABMaYEILTHpTC0ywwAQDTLDAfM5mZ-Ps3cRzXUC8gppteCVGxH4VUwn10NdVkBR-WSkdxUrx4tSX6ALzShUqSEJZJSE1MNBS-L4SfoxumQpesINlvdSHDKJEa67DSpScHNdCyFiGpyWeY5FEI-gjdtKscO7-5qt8SNQAYmHzI_bSrnr-xSrB5HhAUkAljv_8xVfsYYvmE3awvtno1-jLruUbgwgcp5fpD0zjqMk |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sex+Differences+in+the+Association+of+Global+Amyloid+and+Regional+Tau+Deposition+Measured+by+Positron+Emission+Tomography+in+Clinically+Normal+Older+Adults&rft.jtitle=Archives+of+neurology+%28Chicago%29&rft.au=Buckley%2C+Rachel+F&rft.au=Mormino%2C+Elizabeth+C&rft.au=Rabin%2C+Jennifer+S&rft.au=Hohman%2C+Timothy+J&rft.date=2019-05-01&rft.pub=American+Medical+Association&rft.issn=2168-6149&rft.eissn=2168-6157&rft.volume=76&rft.issue=5&rft.spage=542&rft_id=info:doi/10.1001%2Fjamaneurol.2018.4693&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-6149&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-6149&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-6149&client=summon |